Various sequencing studies have identified somatic ZRSR2 mutations in hematological diseases, such as myelodysplastic syndrome (MDS), chronic lymphocytic leukemia (CLL), chronic myelomonocytic leukemia (CMML), or thyroid cancer.11, 12. This evidence concerns the gene ZRSR2 and thyroid cancer.